Mise à jour d'une déclaration précédente
No de la demande: 2013-3836
Numéro de référence du titulaire d'homologation: SC1182527
Nom du titulaire (nom légal complet, aucune abbréviation): Dow AgroSciences Canada Inc.
Adresse: 450-1st Street SW, Suite 2100
Ville: Calgary
État: AB
Pays: Canada
Code postal /Zip: T2P 5H1
Incident chez l'humain
Pays: UNITED STATES
État: FLORIDA
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 62719-4
Nom du produit: Vikane Gas Fumigant
Autre (préciser)
gas fumigantOui
Inconnu
Site: Res. - In Home / Rés. - à l'int. maison
Autre
Sexe: Femme
Âge: >19 <=64 yrs / >19 <=64 ans
Système
Unknown / Inconnu
Oui
Oui
4
Day(s) / Jour(s)
Non professionnel
Contact avec la zone traitée
Temps écoulé entre l'application et l'exposition (contact) 6
Day(s) / Jour(s)
Quelle était l'activité? Please refer to field 13 on Subform II or field 17 of subform III for a detailed description regarding the activity
Aucun
Respiratoire
<=15 min / <=15 min
>24 hrs <=3 days / >24 h <=3 jours
June 8, 2013: Patient's cousin called to report an incident. Home was fumigated on May 23 (Thurs), and the tent removed on Fri 5/24 at 8AM. They were cleared to go back in on 5/24 at 6pm, but did not actually re-enter home until Monday ( 5/27 ). The caller's cousin entered the home May 30. On Saturday (6/1) about noon she began to have a headache and fever (after staying 2 nights in home). The caller took her to hospital, and had temp of 104F with headache, backache, and stiffness of neck. She was released on Wed (June 4) but symptoms returned and was re-admitted on Thursday. The treatment this patient received as well as a diagnosis is not known.
Majeure
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews. Re-entry into a treated dwelling is not permitted until Vikane levels drop below 1 ppm, a level known to be well below the threshold for potential toxicity. There would have been no significant quantities of sulfuryl fluoride in this home 6 days after the home was officially cleared for safe reentry. This is the time by which this patient reentered the home. This patients signs and symptoms are more consistent with an infectious etiology. A link between this patient's illness and the use of Vikane in the home 8 days prior to her onset of illness is biologically implausible.